نتائج البحث 651-660 من 20823 لعملية البحث عن WHO
... who had this procedure performed prior to natural menopause for benign conditions. A Prospective Registry for Patients with REM Sleep Behavior Disorder and ...
... who did not have cancer. The increased risk of HF is observed as early as one year from diagnosis of cancer and overall, 7% of patients develop CHF (median ...
... who had this procedure performed prior to natural menopause for benign conditions. A Phase 3 Efficacy and Safety Study of Pitolisant in Patients with Prader ...
This study is researching an experimental drug called ubamatamab, also referred to as "study drug". The study is focused on patients who have advanced ...
We would like to use your medical records (both existing and future) to study the health of patients who will receive or have received a composite tissue ...
... who have failed 1-2 prior lines of therapy. The primary objectives are to determine the maximum tolerated dose (MTD) or highest protocol-defined dose (HPDD); ...
لا تُقدم Mayo Clinic الدعم للشركات أو المنتجات المُعلَّن عنها هنا. لكن تدعم العائدات الإعلانية رسالتنا غير الربحية.
تحقق من هذه الكتب الأكثر مبيعًا والعروض الخاصة على الكتب والنشرات الإخبارية من Mayo Clinic Press.
تساهم التبرّعات، وهي قابلة للخصم الضريبي، في دعم آخر التطورات في الأبحاث وطرق الرعاية لإحداث نقلة نوعية في الطب.